| Literature DB >> 6366988 |
J S Dixon, N G Sitton, K E Surrall, M F Martin, M E Pickup, H A Bird.
Abstract
Groups of 15 patients with active rheumatoid arthritis were treated for 24 weeks with zinc sulphate, trien, captopril, clozic in two doses or a combination of D-penicillamine and hydroxychloroquine. Serum histidine levels were monitored along with measures of disease activity including C-reactive protein, plasma viscosity, articular index, grip strength and early morning stiffness. Zinc sulphate and trien were found to be ineffective while the other drugs all showed evidence of second-line action. Serum histidine was found to improve during successful therapy. The possible cause of low serum histidine and its response to therapy is discussed.Entities:
Mesh:
Substances:
Year: 1983 PMID: 6366988 DOI: 10.1007/bf00541592
Source DB: PubMed Journal: Rheumatol Int ISSN: 0172-8172 Impact factor: 2.631